National Health Investors, Inc. (NYSE:NHI) – SunTrust Banks issued their Q3 2017 EPS estimates for National Health Investors in a research report issued to clients and investors on Tuesday. SunTrust Banks analyst E. Fleming anticipates that the real estate investment trust will earn $1.33 per share for the quarter. SunTrust Banks has a “Hold” rating and a $80.00 price objective on the stock. SunTrust Banks also issued estimates for National Health Investors’ Q4 2017 earnings at $1.35 EPS, FY2017 earnings at $5.25 EPS, Q1 2018 earnings at $1.34 EPS, Q2 2018 earnings at $1.39 EPS, Q3 2018 earnings at $1.40 EPS, Q4 2018 earnings at $1.41 EPS, FY2018 earnings at $5.54 EPS and FY2019 earnings at $5.80 EPS.
National Health Investors (NYSE:NHI) last released its quarterly earnings data on Wednesday, August 9th. The real estate investment trust reported $0.93 EPS for the quarter, missing the consensus estimate of $1.29 by ($0.36). The company had revenue of $69.84 million during the quarter, compared to analyst estimates of $67.68 million. National Health Investors had a net margin of 59.24% and a return on equity of 12.56%. The company’s quarterly revenue was up 14.1% compared to the same quarter last year. During the same period in the previous year, the company posted $1.22 EPS. ILLEGAL ACTIVITY NOTICE: “SunTrust Banks Weighs in on National Health Investors, Inc.’s Q3 2017 Earnings (NHI)” was first published by Markets Daily and is owned by of Markets Daily. If you are viewing this news story on another publication, it was illegally stolen and reposted in violation of United States and international copyright & trademark legislation. The original version of this news story can be viewed at https://www.themarketsdaily.com/2017/10/13/suntrust-banks-weighs-in-on-national-health-investors-inc-s-q3-2017-earnings-nhi.html.
Several other brokerages also recently issued reports on NHI. Zacks Investment Research downgraded National Health Investors from a “buy” rating to a “hold” rating in a report on Wednesday, September 6th. KeyCorp reiterated a “hold” rating on shares of National Health Investors in a report on Sunday, September 17th. BidaskClub upgraded National Health Investors from a “hold” rating to a “buy” rating in a report on Thursday, June 29th. Finally, Mizuho reiterated a “neutral” rating on shares of National Health Investors in a report on Wednesday, June 28th. One equities research analyst has rated the stock with a sell rating, six have issued a hold rating and two have issued a buy rating to the company’s stock. The company currently has an average rating of “Hold” and an average target price of $80.17.
The firm also recently disclosed a quarterly dividend, which will be paid on Friday, November 10th. Shareholders of record on Friday, September 29th will be given a $0.95 dividend. The ex-dividend date is Thursday, September 28th. This represents a $3.80 annualized dividend and a yield of 4.94%. National Health Investors’s dividend payout ratio is currently 97.69%.
In other news, insider Kevin Carlton Pascoe sold 2,000 shares of the company’s stock in a transaction on Thursday, August 24th. The stock was sold at an average price of $79.80, for a total transaction of $159,600.00. Following the transaction, the insider now owns 21,228 shares of the company’s stock, valued at approximately $1,693,994.40. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. 5.19% of the stock is owned by corporate insiders.
Several hedge funds and other institutional investors have recently modified their holdings of NHI. BlackRock Inc. lifted its position in shares of National Health Investors by 6,473.4% during the 1st quarter. BlackRock Inc. now owns 3,328,567 shares of the real estate investment trust’s stock valued at $241,753,000 after buying an additional 3,277,930 shares during the last quarter. Vanguard Group Inc. lifted its holdings in National Health Investors by 3.3% during the 1st quarter. Vanguard Group Inc. now owns 6,219,436 shares of the real estate investment trust’s stock worth $451,717,000 after purchasing an additional 201,133 shares in the last quarter. Nuveen Asset Management LLC purchased a new stake in National Health Investors during the 1st quarter worth about $11,559,000. Marshall Wace North America L.P. purchased a new stake in National Health Investors during the 1st quarter worth about $6,794,000. Finally, MARSHALL WACE ASIA Ltd purchased a new stake in National Health Investors during the 1st quarter worth about $6,794,000. 70.67% of the stock is currently owned by hedge funds and other institutional investors.
About National Health Investors
National Health Investors, Inc is a self-managed real estate investment trust (REIT) specializing in sale-leaseback, joint-venture, mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. The Company is engaged in the business of owning and financing healthcare properties.
Receive News & Ratings for National Health Investors Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for National Health Investors Inc. and related companies with MarketBeat.com's FREE daily email newsletter.